IMMNOV.ST
Immunovia AB (publ) [IMMNOV.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IMMNOV.ST Stock Summary
Top 10 Correlated ETFs
IMMNOV.ST
Top 10 Correlated Stocks
IMMNOV.ST
In the News
IMMNOV.ST Financial details
Company Rating
-
Market Cap
76.81M
Income
-312M
Revenue
1.58M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
11
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-0.27
Forward P/E
-
PEG
-0.06
P/S
57.15
P/B
1
P/C
-
P/FCF
-0.64
Quick Ratio
3.03
Current Ratio
3.2
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-8.75
EPS next Y
-
EPS next Q
-
EPS this Y
52.44%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.81%
Revenue last 5Y
34.62%
Revenue Q/Q
-68.24%
EPS Q/Q
58.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-232%
ROE
-209%
ROC
-2.83%
Gross Margin
-296%
Oper. Margin
-16864%
Profit Margin
-18031%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.514-6.37
52W High
-
52W Low
-
RSI
42
Rel Volume
1.6
Avg Volume
659.93K
Volume
1.06M
Perf Week
-1.48%
Perf Month
-31.44%
Perf Quarter
-56.96%
Perf Half Y
-58.63%
-
-
-
-
Beta
2.73
-
-
Volatility
0%, 0.02%
Prev Close
0%
Price
0.266
Change
-1.3%
Company Profile
- Volume Average 659.93K
- Market Capitalization 76.81M
- Employee 11
- CEO Mr. Jeff Borcherding
- Headquarters Lund,SE
- IPO Date 2015-12-01
-
Website
https://www.immunovia.com 
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
